{"pmid":32346988,"title":"Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice.","text":["Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice.","Pediatr Diabetes","32346988"],"journal":"Pediatr Diabetes","date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346988","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/pedi.13013","topics":["Prevention"],"weight":1,"_version_":1666138495407620096,"score":9.490897,"similar":[{"pmid":32285556,"title":"Care for diabetes with COVID-19: Advice from China.","text":["Care for diabetes with COVID-19: Advice from China.","J Diabetes","Wang, Weiqing","Lu, Jieli","Gu, Weiqiong","Zhang, Yifei","Liu, Jianmin","Ning, Guang","32285556"],"journal":"J Diabetes","authors":["Wang, Weiqing","Lu, Jieli","Gu, Weiqiong","Zhang, Yifei","Liu, Jianmin","Ning, Guang"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285556","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/1753-0407.13036","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491306639361,"score":68.956245},{"pmid":32361966,"title":"A safe flight for children through COVID-19 disaster: keeping our mind open!","text":["A safe flight for children through COVID-19 disaster: keeping our mind open!","Eur J Pediatr","de Winter, J Peter","de Winter, Derek","Bollati, Valentina","Milani, Gregorio P","32361966"],"journal":"Eur J Pediatr","authors":["de Winter, J Peter","de Winter, Derek","Bollati, Valentina","Milani, Gregorio P"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361966","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s00431-020-03668-7","topics":["Prevention"],"weight":1,"_version_":1666138495530303489,"score":68.81268},{"pmid":32379036,"title":"Keep Calm and Log On: Telemedicine for COVID-19 Pandemic Response.","text":["Keep Calm and Log On: Telemedicine for COVID-19 Pandemic Response.","J Hosp Med","Doshi, Ameet","Platt, Yonatan","Dressen, John R","Mathews, Benji K","Siy, Jerome C","32379036"],"journal":"J Hosp Med","authors":["Doshi, Ameet","Platt, Yonatan","Dressen, John R","Mathews, Benji K","Siy, Jerome C"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379036","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12788/jhm.3419","topics":["Prevention"],"weight":1,"_version_":1666597097295577088,"score":68.01441},{"pmid":32315948,"pmcid":"PMC7153521","title":"Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","text":["Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery.","Diabetes Metab Syndr","Baretic, Maja","32315948"],"abstract":["A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery."],"journal":"Diabetes Metab Syndr","authors":["Baretic, Maja"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315948","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.dsx.2020.04.014","keywords":["chloroquine","hypoglycaemia","remission","type 1 diabetes"],"e_drugs":["Chloroquine"],"topics":["Prevention"],"weight":1,"_version_":1666138493563174913,"score":60.116436},{"pmid":32312362,"title":"[Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak].","text":["[Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak].","Coronavirus disease 2019 (COVID-19) is the most serious public health problem in China. Children with diabetes are also among the population susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Traffic problems caused by epidemic prevention and control increase the difficulty in the management of children with severe diabetes. In order to control the spread of epidemic, children with mild diabetes are advised to be managed at home and in the community. However, how to treat children with severe diabetes effectively and safely during the outbreak of COVID-19 brings great challenges to primary doctors. The Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Association and the Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Doctor Association have developed the recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak, which provide a reference for primary doctors to quickly assess the severity of patient's condition and treat the illness accordingly, thus reducing the risk of referral infection and improving clinical prognosis.","Zhongguo Dang Dai Er Ke Za Zhi","32312362"],"abstract":["Coronavirus disease 2019 (COVID-19) is the most serious public health problem in China. Children with diabetes are also among the population susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Traffic problems caused by epidemic prevention and control increase the difficulty in the management of children with severe diabetes. In order to control the spread of epidemic, children with mild diabetes are advised to be managed at home and in the community. However, how to treat children with severe diabetes effectively and safely during the outbreak of COVID-19 brings great challenges to primary doctors. The Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Association and the Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Doctor Association have developed the recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak, which provide a reference for primary doctors to quickly assess the severity of patient's condition and treat the illness accordingly, thus reducing the risk of referral infection and improving clinical prognosis."],"journal":"Zhongguo Dang Dai Er Ke Za Zhi","date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312362","source":"PubMed","week":"202017|Apr 20 - Apr 26","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138493424762880,"score":52.3892}]}